Clearstead Advisors’s Globus Medical GMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $8.7K | Sell |
101
-637
| -86% | -$57.2K | ﹤0.01% | 1624 |
|
|
2025
Q4 | $64.4K | Buy |
738
+408
| +124% | +$31K | ﹤0.01% | 1291 |
|
|
2025
Q3 | $18.9K | Sell |
330
-213
| -39% | -$12.3K | ﹤0.01% | 1662 |
|
|
2025
Q2 | $32K | Buy |
543
+80
| +17% | +$5.17K | ﹤0.01% | 1436 |
|
|
2025
Q1 | $33.9K | Buy |
463
+91
| +24% | +$7.52K | ﹤0.01% | 1273 |
|
|
2024
Q4 | $30.8K | Hold |
372
| – | – | ﹤0.01% | 1276 |
|
|
2024
Q3 | $26.6K | Hold |
372
| – | – | ﹤0.01% | 1351 |
|
|
2024
Q2 | $25.5K | Buy |
372
+322
| +644% | +$19.2K | ﹤0.01% | 1313 |
|
|
2024
Q1 | $3.19K | Hold |
50
| – | – | ﹤0.01% | 1247 |
|
|
2023
Q4 | $2.67K | Sell |
50
-50
| -50% | -$2.44K | ﹤0.01% | 1249 |
|
|
2023
Q3 | $4.97K | Buy |
100
+50
| +100% | +$2.8K | ﹤0.01% | 1242 |
|
|
2023
Q2 | $2.98K | Hold |
50
| – | – | ﹤0.01% | 1100 |
|
|
2023
Q1 | $2.83K | Hold |
50
| – | – | ﹤0.01% | 1087 |
|
|
2022
Q4 | $3.71K | Hold |
50
| – | – | ﹤0.01% | 1012 |
|
|
2022
Q3 | $3K | Hold |
50
| – | – | ﹤0.01% | 1029 |
|
|
2022
Q2 | $3K | Hold |
50
| – | – | ﹤0.01% | 1053 |
|
|
2022
Q1 | $4K | Hold |
50
| – | – | ﹤0.01% | 1102 |
|
|
2021
Q4 | $4K | Sell |
50
-379
| -88% | -$27.5K | ﹤0.01% | 1018 |
|
|
2021
Q3 | $33K | Buy |
429
+379
| +758% | +$30.4K | ﹤0.01% | 680 |
|
|
2021
Q2 | $4K | Hold |
50
| – | – | ﹤0.01% | 915 |
|
|
2021
Q1 | $3K | Hold |
50
| – | – | ﹤0.01% | 919 |
|
|
2020
Q4 | $3K | Hold |
50
| – | – | ﹤0.01% | 848 |
|
|
2020
Q3 | $2K | Buy |
+50
| New | +$2.58K | ﹤0.01% | 814 |
|
Other funds holding GMED
VCM
VPM
SC